New hope for kids with recurrent brain cancer: targeted radiation delivered to the brain
NCT ID NCT04743661
Summary
This study is testing a new combination treatment for children and young adults whose medulloblastoma or ependymoma brain tumors have come back. The main goal is to see if adding a targeted radiation treatment, delivered directly into the fluid-filled spaces of the brain, can help control the cancer and improve survival. The treatment involves attaching a radioactive particle to an antibody that seeks out the tumor cells.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RECURRENT EPENDYMOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Children's Hospital Los Angeles
Los Angeles, California, 90027, United States
-
Cincinnati Children's Hospital Medical Center
Cincinnati, Ohio, 45229, United States
-
Memorial Sloan Kettering Cancer Center
New York, New York, 10065, United States
Conditions
Explore the condition pages connected to this study.